Delivery Order SPE2DE24D0013-SPE2D626F9784
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain on November 7, 2025, with an ultimate completion date of November 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and relates to molecular diagnostic testing supplies, specifically reagent cartridges and test kits for detecting COVID-19, influenza, and...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,236 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on October 29, 2025, with an ultimate completion date of November 13, 2025. The contract, designated as XPCOV2/FLU/RSV-10, is for molecular diagnostic testing supplies and reagents, likely including test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. No...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $4,320 on November 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated 4569923600 XPCOV2/FLU/RSV-10, is scheduled for completion by November 13, 2025, and represents procurement of diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The contract carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 delivery order (4569923616) by the Defense Logistics Agency Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The contract is for XPCOV2/FLU/RSV-10 diagnostic products—molecular testing reagents and cartridges for detecting COVID-19, influenza, and respiratory syncytial virus on the GeneXpert diagnostic platform. This is a firm fixed-price delivery order with no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F9784Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing for infectious diseases. The award utilized no set-aside designation, reflecting Cepheid's established competitive position as a primary federal supplier of diagnostic solutions. This contract was performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a continuation of the Defense Logistics Agency Medical Supply Chain's reliance on Cepheid for diagnostic testing supplies and reagents that support federal healthcare operations. Cepheid has demonstrated substantial capability across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, with a portfolio encompassing GeneXpert diagnostic systems, molecular testing assays, and maintenance services. The company's extensive federal contract history—including indefinite delivery contracts valued at over $39 million with the Department of Veterans Affairs—establishes Cepheid as a critical supplier for molecular diagnostic capabilities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 11/5/25 |